Indirect comparisons of ranibizumab and dexamethasone in macular oedema secondary to retinal vein occlusion

被引：0
|
作者：
Howard HZ Thom
Gorana Capkun
Richard M Nixon
Alberto Ferreira
机构：
[1] University of Bristol,School of Social and Community Medicine
[2] Novartis Pharma,undefined
来源：
BMC Medical Research Methodology | / 14卷
关键词：
Ranibizumab; Dexamethasone; Retinal vein occlusion; Central retinal vein occlusion; Branch retinal vein occlusion; Macular oedema; Evidence synthesis; Indirect comparison;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] INTRAVITREAL RANIBIZUMAB FOR MACULAR EDEMA SECONDARY TO CENTRAL RETINAL VEIN OCCLUSION
    Risard, Sarah M.
    Pieramici, Dante J.
    Rabena, Melvin D.
    Basefsky, Jessica C.
    Avery, Robert L.
    Castellarin, Alessandro A.
    Nasir, Ma'an A.
    See, Robert F.
    Couvillion, Stephen S.
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2011, 31 (06): : 1060 - 1067
  • [22] Two-year outcomes of intravitreal (IVT) ranibizumab for macular oedema secondary to branch retinal vein occlusion (BRVO) and central retinal vein occlusion (CRVO)
    Juma, Z.
    Tyagi, P.
    Santiago, C.
    Ionean, A.
    EYE, 2017, 31 : S16 - S16
  • [23] Comparison of intravitreal ranibizumab monotherapy vs. ranibizumab combined with dexamethasone implant for macular edema secondary to retinal vein occlusion
    Liang, Xuemei
    Shen, Baiyun
    Ou, Zuguo
    An, Hongmei
    Li, Li
    FRONTIERS IN MEDICINE, 2022, 9
  • [24] Aflibercept: A Review in Macular Oedema Secondary to Branch Retinal Vein Occlusion
    Hoy, Sheridan M.
    DRUGS & AGING, 2017, 34 (05) : 393 - 400
  • [25] Intravitreal bevacizumab for macular oedema secondary to branch retinal vein occlusion
    K Gündüz
    S J Bakri
    Eye, 2008, 22 : 1168 - 1171
  • [26] Intravitreal bevacizumab for macular oedema secondary to branch retinal vein occlusion
    Guenduez, K.
    Bakri, S. J.
    EYE, 2008, 22 (09) : 1168 - 1171
  • [27] Aflibercept: A Review in Macular Oedema Secondary to Branch Retinal Vein Occlusion
    Sheridan M. Hoy
    Drugs & Aging, 2017, 34 : 393 - 400
  • [28] COSTS ASSOCIATED WITH THE MANAGEMENT AND MORBIDITY OF DIABETIC MACULAR OEDEMA AND MACULAR OEDEMA SECONDARY TO RETINAL VEIN OCCLUSION
    Balana, M.
    Abraldes, M.
    Pareja, A.
    Roura, M.
    VALUE IN HEALTH, 2015, 18 (07) : A418 - A418
  • [29] Outcome of intravitreal dexamethasone implant for the treatment of ranibizumab-resistant macular edema secondary to retinal vein occlusion
    Kleanthis Manousaridis
    Silvia Peter
    Stefan Mennel
    International Ophthalmology, 2017, 37 : 47 - 53
  • [30] Outcome of intravitreal dexamethasone implant for the treatment of ranibizumab-resistant macular edema secondary to retinal vein occlusion
    Manousaridis, Kleanthis
    Peter, Silvia
    Mennel, Stefan
    INTERNATIONAL OPHTHALMOLOGY, 2017, 37 (01) : 47 - 53
12345